This would trigger an inflammatory response in the liver by activating the TLR4/NF-κB signaling pathway and promoting the translocation of p65 to the nucleus, which is responsible for the release of inflammatory mediator such as IL-6, ultimately leading to NAFLD [22]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.